Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Annals of Surgical Oncology|January 3, 2021
Inaccurate Clinical Stage Is Common for Gastric Adenocarcinoma and Is Associated with Undertreatment and Worse OutcomesMichelle R Ju, John D Karalis, James-Michael Blackwell, et al.Annals of Surgical Oncology|January 14, 2022
Nativity Status is an Important Social Determinant of Health for Hispanic Patients with Gastric Cancer in TexasMichelle R Ju, John D Karalis, Archana Bhat, et al.Cancers|June 13, 2025
The Current State of Tumor Microenvironment-Specific Therapies for Non-Small Cell Lung CancerRaghav Chandra, Jasmina Ehab, Edward Hauptmann, et al.Annals of Surgical Oncology|March 25, 2023
Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?Gilbert Z Murimwa, John D Karalis, Jennie Meier, et al.Annals of Surgical Oncology|March 30, 2025
Pre-existing Mental Health Disorders are Associated with Disparities in Gastric Cancer Care: An American Combined Safety Net and Teaching Hospital ExperienceMorgan F Pettigrew, Andres A Abreu, Amr I Al Abbas, et al.Journal of Surgical Oncology|December 8, 2023
Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascitesJohn D Karalis, Michelle R Ju, Rachel Feig, et al.International Journal of Radiation Oncology, Biology, Physics|July 27, 2022
Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve OutcomesAhmed M Elamir, John D Karalis, Nina Niu Sanford, et al.Nature Communications|February 10, 2022
Development and validation of a prognostic and predictive 32-gene signature for gastric cancerJae-Ho Cheong, Sam C Wang, Sunho Park, et al.Annals of Surgical Oncology|December 27, 2023
Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer PatientsKai Wang, John D Karalis, Ahmed Elamir, et al.Journal of Translational Medicine|March 8, 2022
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous populationJohn D Karalis, Lynn Y Yoon, Suntrea T G Hammer, et al.Pageof 3